Vitamin D Testing Market in the US 2015-2019
|発行||TechNavio (Infiniti Research Ltd.)||商品コード||347970|
|出版日||ページ情報||英文 72 Pages
|米国のビタミンD検査市場 (2015〜2019年) Vitamin D Testing Market in the US 2015-2019|
|出版日: 2015年12月23日||ページ情報: 英文 72 Pages||
米国国内のビタミンD検査市場は、今後は安定的な成長を遂げていくと見られています。同市場の2019年までの年平均成長率 (CAGR) は約4%と推計されています。様々な急性・慢性疾患の予防が、主な市場成長要因となっています。ビタミンDの欠乏症は、くる病や骨粗鬆症といった慢性疾患や、幼児期での心血管疾患・がん・ぜんそく発症、認知障害、自己免疫などを引き起こす可能性があります。逆に、ビタミンDの水準を頻繁に検査することで、こうした疾患を予防し、更には全体的な医療費負担を抑えることが可能となります。主な検査項目には、25-ヒドロキシビタミンD検査と1, 25-ジヒドロキシビタミンD検査の2種類がありますが、全社が全体の約76%を占めています。
Technavio's market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019.
The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn would help to reduce the overall healthcare expenditure.
In this market research report, analysts estimate the 25-Hydroxy vitamin D tests segment to be the largest market segment during the forecast period. Currently, this market segment accounts for a share of nearly 76% and is envisaged to retain its dominating hold over the market by 2019. The ability of 25-Hydroxy vitamin D tests to identify bone malformations and softness, bone weakness, or fractures in adults is one of the most significant factors that accounts for its high market share during the forecast period.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
This market is highly competitive and consists of vendors that focus on test development and research. These vendors compete on the basis of price, quality, and breadth of product line, technology, and distribution capabilities to gain maximum prominence in the market.
Key vendors in this market are -
Other prominent vendors analyzed in this market research are Diazyme laboratories, Biokit, ESA Biosciences, Quest Diagnostics Inc., The Vitamin D Company, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.
Upcoming trends such as the augmented adoption of home vitamin D testing kits are rapidly gaining popularity as they are highly cost efficient. Since this market is facing declining reimbursement, patients have to pay out of their pockets to perform these tests. Therefore, in recent times, it has been observed that many patients prefer carrying out such tests at the convenience of their homes as it reduces the overall expenditure.
This report provides a number of factors contributing to the adoption, limitations, and opportunities of the vitamin D testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.